Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine

…, D Zou, W Liu, J Yang, N Zhu, L Huo… - The Journal of …, 2008 - academic.oup.com
Objective: The objective of the study was to develop clinical practice guidelines for the
diagnosis of Cushing's syndrome. Participants: The Task Force included a chair, selected by the …

[HTML][HTML] Toxicity of nanoparticles on the reproductive system in animal models: a review

…, ZU Rehman, F Farmanullah, LJ Huo - Frontiers in …, 2017 - frontiersin.org
In the last two decades, nanotechnologies demonstrated various applications in different
fields, including detection, sensing, catalysis, electronics, and biomedical sciences. However, …

Construction of three-dimensional flower-like α-MoO3 with hierarchical structure for highly selective triethylamine sensor

…, XL Cheng, S Gao, H Zhao, Z Cai, LH Huo - Sensors and Actuators B …, 2015 - Elsevier
Novel flower-like α-MoO 3 with hierarchical structure was synthesized via a facile solvothermal
route without any surfactant or template, and subsequent calcination at 400 C in air for 2 h…

Advanced treatment of landfill leachate by a new combination process in a full-scale plant

H Li, S Zhou, Y Sun, P Feng - Journal of Hazardous Materials, 2009 - Elsevier
Advanced treatment of mature landfill leachate from a municipal landfill located in southern
China (Jiangmen) was carried out in a full-scale plant using a new process. The combined …

[HTML][HTML] Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial

L Gao, BW Lee, M Chawla, J Kim, L Huo, L Du… - Nature Medicine, 2023 - nature.com
Tirzepatide is a once-weekly GIP/GLP-1 receptor agonist. In this phase 3, randomized, open-label
trial, insulin-naive adults (≥18 years of age) with type 2 diabetes (T2D) uncontrolled …

Comparison of PET imaging of activated fibroblasts and 18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study

…, J Congwei, H Zhao, M Hacker, L Huo, X Li - European Journal of …, 2021 - Springer
Purpose This study aimed to compare the performance of 68 Ga-labelled fibroblast activating
protein inhibitor (FAPI) PET and 18 F-FDG PET for imaging of hepatic tumours. Methods …

Fibroblast imaging of hepatic carcinoma with 68Ga-FAPI-04 PET/CT: a pilot study in patients with suspected hepatic nodules

…, F Li, S Yao, H Zhang, H Zhao, M Hacker, L Huo… - European journal of …, 2021 - Springer
Purpose 68 Ga-FAPI-04 is a rapidly evolving PET tracer for whole-body imaging in a variety
of cancers. We aimed to evaluate the diagnostic performance of 68 Ga-FAPI-04 for detecting …

[HTML][HTML] Pembrolizumab combined with lenvatinib as non-first-line therapy in patients with refractory biliary tract carcinoma

…, J Pan, K Hu, M Guan, L Zhao, L Huo… - … surgery and nutrition, 2020 - ncbi.nlm.nih.gov
Background A therapeutic strategy involving combined treatment with lenvatinib plus
pembrolizumab (LEP) has demonstrated a relatively high antitumor response in several solid …

Facile synthesis and excellent electrochemical performance of reduced graphene oxide–Co 3 O 4 yolk-shell nanocages as a catalyst for oxygen evolution reaction

Z Wu, LP Sun, M Yang, LH Huo, H Zhao… - Journal of materials …, 2016 - pubs.rsc.org
The development of highly active, inexpensive and clean catalysts for applications in the
oxygen evolution reaction (OER) is very important for energy storage and conversion. In this …

A fully biodegradable and self-electrified device for neuroregenerative medicine

…, H Hou, H Li, W Lu, Y Zhao, J Wang, Y Zhu, Y Li… - Science …, 2020 - science.org
Peripheral nerve regeneration remains one of the greatest challenges in regenerative
medicine. Deprivation of sensory and/or motor functions often occurs with severe injuries even …